NanoViricides Inc. (NNVC)

[Ubertino]

Re: Wellcome Trust Consortium

[e-mail]
10:20 AM (1 hour ago)

to me

We need to first test EbolaCide2 in a BSL-4 lab. If it meets our expectations, then it’s off to Africa we go

Remember, we’re still focussed on FluCide which is the basis of a sustainable, $25B per annum business

Ebola is topical and these Ebola-centric companies may well disappear when the epidemic is finally controlled.

They’re just one hit wonders

It’s all about sustainability with a product line that has significant depth

Tekmira has received $143M and has been working on Ebola for years

I also wonder just how much they can produce and in what period of time!

Mapp has stated they can make 20-40 doses per month.

Don’t forget that we just restarted the program one month ago

Sincerely,

Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
[e-mail]
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange

On Sep 23, 2014, at 7:10 AM, I wrote:

Dear Gene;

Are we involved in the Wellcome Trust Consortium?

Ref:
http://www.marketwatch.com/story/tekmira-joins-international-consortium-to-conduct-clinical-trials-of-ebola-virus-therapeutics-in-west-africa-2014-09-23

Me